T1	Participants 95 133	adults with autism spectrum disorders.
T2	Participants 610 759	11 adults with autism or Aspergers disorder and 8 age- and gender-matched healthy controls via randomized double-blind, m-CPP and placebo challenges.
T3	Participants 920 959	Patients with autism spectrum disorders
T4	Participants 1088 1127	subjects with autism spectrum disorders
